亚辉龙 (688575.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

14.9x

Market Cap

CNY 5.26B

MomentumView details →

1D Return

−3.66%

YTD Return

—

RSI (14)

55.0

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

14.9x

Market Cap

CNY 5.26B

RSI (14)

55.0

MomentumView details →

1D Return

−3.66%

YTD Return

—

ProfitabilityView details →

Gross Margin

65.53%

Net Margin

1.74%

EBITDA Margin

22.78%

ROE (TTM)

1.15%

ROA (TTM)

0.72%

Asset Turnover

0.42x

GrowthView details →

Revenue YoY

−10.38%

EPS YoY

−86.22%

FCF YoY

+541.31%

Revenue CAGR 3Y

−23.10%

EPS CAGR 3Y

−71.83%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.09

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.00

Avg Surprise (4Q)

—

Rev Surprise

−1.09%

Capital & dividendView details →

Debt/Equity

0.34x

Current Ratio

2.19x

Quick Ratio

1.53x

Div Yield

0.21%

Div Rate

CNY 0.02

Div Growth 1Y

−90.00%

Financials snapshotView financials →

Revenue (TTM)

1.79B

Net Income (TTM)

31.14M

Op. CF (TTM)

506.11M

Next earningsOct 26, 2026 →

Latest newsMore news →

Yalun Biotechnology received medical device registration certificates from Guangdong Provincial Drug Administration for two microfluidic chemiluminescence immunoassay analyzers (iNexaLume-A and iNexaLume-B), valid until August 12, 2031.18d ago

Similar companies

普门科技688389.SH 翔宇医疗688626.SH 东方生物688298.SH 安旭生物688075.SH 健麾信息605186.SH Jenscare Scientific Co., Ltd.09877.HK Find similar companies →

Latest newsMore news →

Yalun Biotechnology received medical device registration certificates from Guangdong Provincial Drug Administration for two microfluidic chemiluminescence immunoassay analyzers (iNexaLume-A and iNexaLume-B), valid until August 12, 2031.18d ago